On May 21, 2025, Vaxart, Inc. announced that it adjourned its annual meeting of stockholders to allow more time for votes on pending proposals, with the meeting rescheduled for June 2, 2025. The proposal voting was not conducted as the board desired to give stockholders adequate time to participate.